According to the 2016 World Health Organization (WHO) classification of Central Nervous System tumors, establishing whether a brain tumor is IDH mutated or wild-type (WT) is a crucial requisite for the classification of gliomas18. The gene discussed is IDH1; the disease is central nervous system cancer.